Curative treatment of low-risk prostate cancer (LR-PCa) does not improve cancer specific survival and active surveillance (AS) is recommended. Although AS is cost-effective and reduces treatment-related complications, it requires psychosocial support. Research on psychosocial interventions specifically focused on men undergoing AS is limited. Aim of this study is to reach consensus amongst relevant stakeholders on selecting interventions offering psychosocial support to PCa patients during AS.
In accordance with the RAND/UCLA method, a modified Delphi approach was used to establish consensus on selecting interventions. During phase one, interventions were identified through a literature review and open survey among all participants. During phase two, three consensus rounds were conducted to rate potential interventions and obtain statistical consensus. The IQ healthcare consensus tool was used to calculate statistical consensus.
After the first consensus round, 31 participants scored individual interventions on relevance using a 9-point Likert scale resulting in the selection of 6 interventions. During the second consensus round 13 discussion items were reviewed during a focus group. After the third consensus round, 7 additional interventions were selected by 23 participants.
In total, 13 interventions were selected for inclusion in a support program. This included four interventions within the domain information and education, three within coping and support, one intervention within physical wellbeing and four within the domain lifestyle. This article is protected by copyright. All rights reserved.
Psycho-oncology. 2022 Oct 17 [Epub ahead of print]
Kim Donachie, Marian Adriaansen, Minke Nieuwboer, Erik Cornel, Esther Bakker, Lilian Lechner
HAN University of Applied Sciences, Academy of Health, Nijmegen, the Netherlands., Hogeschool van Arnhem en Nijmegen Instituut Verpleegkundige Studies, Nijmegen, the Netherlands., Ziekenhuisgroep Twente, Hengelo, the Netherlands., Open University, Faculty of Psychology and Educational Sciences, Heerlen, the Netherlands.